Updating a systematic review - What difference did it make? Case study of nicotine replacement therapy

BMC Medical Research Methodology

Volumn 1, Issue , 2001, Pages 1-5

  Stead, Lindsay F ^a   Lancaster, Tim ^a   Silagy, Chris A ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; NICOTINE DERIVATIVE; NICOTINE GUM; NICOTINE PATCH; PLACEBO; UNCLASSIFIED DRUG;

CLINICAL TRIAL; DRUG EFFECT; HUMAN; META ANALYSIS; NICOTINE REPLACEMENT THERAPY; OUTCOMES RESEARCH; REVIEW; RISK; SMOKING CESSATION; STATISTICAL SIGNIFICANCE; TOBACCO DEPENDENCE; TREATMENT OUTCOME;

EID: 3042797559     PISSN: 14712288     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2288-1-10     Document Type: Review

References (14)

1. Higgins J: How should we interpret updated meta-analyses? [Abstract]. VII Cochrane Colloquium. The best evidence for health care: The role of the Cochrane Collaboration; 1999 October; Rome
2. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC: Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992, 327:248-254
3. Silagy C, Mant D, Fowler G, Lodge M: Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994, 343:139-142
4. Silagy C, Mant D, Fowler G, Lancaster T: Nicotine replacement therapy for smoking cessation (Cochrane Review). In: The Cochrane Library, Issue 4, 2000. Oxford: Update Software
5. Yusuf S, Peto R, Lewis J, Collins R, Sleight P: Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985, 27(5);:335-371
6. Transdermal nicotine for smoking cessation: Six-month results from two multicenter controlled clinical trials. Transdermal Nicotine Study Group. JAMA 1991, 266:3133-3138
7. Rothwell PM: Can overall results of clinical trials be applied to all patients? [see comments]. Lancet 1995, 345:1616-1619
8. Randomised trial of nicotine patches in general practice: results at one year. Imperial Cancer Research Fund General Practice Research Group. BMJ 1994, 308:1476-1477
9. Stapleton JA, Russell MAH, Feyerabend C, Wiseman SM, Gustavsson G, Sawe U, et al: Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction 1995, 90:31-42
10. Joseph AM, Norman SM, Ferry LH, Prochazka AV, Westman EC, Steele BG, et al: The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996, 335:1792-1798
11. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, et al: A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999, 340:685-91
12. Glasziou PP, Irwig LM: An evidence based approach to individualising treatment. BMJ 1995, 311:1356-1359
13. Stem JM, Simes RJ: Publication bias: evidence of delayed publication in a cohort study of clinical research projects. BMJ 1997, 315:640-645
14. Egger M, Smith GD: Misleading meta-analysis. BMJ 1995, 310:752-4